Increased risk for atherosclerosis of various macrophage scavenger receptor 1 alleles

Ronen Durst1, Yehuda Neumark, Vardiella Meiner

  • 1Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. rdurst@partners.org

Abstract

Insights

Genetic variations in the Macrophage Scavenger Receptor 1 (MSR1) gene are linked to atherosclerosis. These MSR1 polymorphisms may influence cardiovascular disease risk beyond traditional factors.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Molecular Biology

Background:

  • Macrophage scavenger receptor 1 (MSR1) facilitates modified low-density lipoprotein (LDL) uptake.
  • The role of MSR1 in atherosclerosis development is not fully understood, particularly in human genetic studies.

Purpose of the Study:

  • To investigate the association between MSR1 gene polymorphisms and susceptibility to atherosclerosis.
  • To determine if MSR1 variations impact the severity of coronary artery disease.

Main Methods:

  • Genotyping of three MSR1 polymorphisms (rs3036811, rs33959637, rs3747531) in 136 nondiabetic men.
  • Coronary artery disease severity assessed by stenosis percentage (CAGE > 20%, CAGE > 50%) and number of diseased vessels.
  • Linear regression analysis to correlate MSR1 genotypes and haplotypes with atherosclerotic burden.

Main Results:

  • A significant association was found between the MSR1 IVS5-59 polymorphism and the number of diseased vessels (p=0.009).
  • The IVS5-59 polymorphism also showed a significant association with coronary artery narrowing greater than 20% (p=0.017).
  • These associations remained significant after adjusting for age, cholesterol, hypertension, and smoking status.

Conclusions:

  • MSR1 gene polymorphisms are associated with atherosclerosis.
  • MSR1 variations may modify the risk of atherosclerosis conferred by established risk factors.
  • These findings highlight a significant role for MSR1 in the pathogenesis of atherosclerosis.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...